Asfotase alfa

Active ingredient description

Asfotase alfa, a human recombinant tissue-nonspecific alkaline phosphatase-Fc-deca-aspartate fusion protein with enzymatic activity, promotes mineralisation of the skeleton in patients with hypophosphatasia.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB13

Medicines

Asfotase alfa is the active ingredient of these drugs:

Drug
Countries

Austria Brazil Canada Estonia Finland

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)

External identifiers

CAS Substance: 1174277-80-5
DrugBank Drug: DB09105
KEGG Drug: D10595
RxNorm Ingredient: 1720259
SNOMED-CT Concept: 715255009
Asfotase alfa (substance)
UNII Identifier: Z633861EIM
ASFOTASE ALFA